Aktuellt
SENASTE
Redeye is impressed and relieved by yesterday’s news that Nanexa has signed an exclusivity- and evaluation agreement with Novo Nordisk worth SEK46m. In connection with the agreement, a directed issue of SEK17m was also conducted to Novo Nordisk. We give our initial take.
LÄS MER
